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Is cardiac surgery warranted in children with Down 
syndrome? 
A case-controlled review 
M A Roussot, J B Lawrenson, J Hewitson, R Smart, H P de Decker 
Objectives. To compare children with Down syndrome and 
children without Down syndrome and investigate whether 
there is a significant difference in the burden that is placed 
on the health care system between these two groups only in 
respect of the repair of congenital heart disease at Red Cross War 
Memorial Children's Hospital, Cape Town, South Africa. 
Design. This study is a retrospective case control review. 
Setting. Red Cross War Memorial Children's Hospital, Cape 
Town, South Africa. 
Subjects. The sample group of 50 Down syndrome children 
who had received cardiac surgery between January 1998 and 
June 2003 was compared with a control group of 50 non-
syndromic children who had received cardiac surgery during 
the same period. 
Outcome measures. Sex and diagnoses (cardiac and non-
cardiac), number of days spent in hospital and in ICU, 
Despite an increasing level of skill and technological capacity to 
provide health care, public health care systems worldwide are 
being placed under mounting pressure to deliver essential health 
care with limited resources, South Africa being no exception.1 
Approximately 40 - 50%2-4 of children with Down syndrome 
have congenital heart defects that may be corrected surgically. 
Down syndrome children are at risk of being discriminated 
against in the allocation of scarce resources as it may be 
perceived that they place a greater burden on the public health 
care system and are less likely to have a favourable outcome 
to surgical treatment than non-Down syndrome children. 
A belief exists that the contribution that a Down syndrome 
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complication rates, re-operation rates, early mortality rates, 
planned further cardiac surgery. Costs of these outcomes were 
not quantified in exact monetary terms. 
Results. There was no significant difference between the two 
groups in terms of the burden that was placed on the health 
care system. Similar complication rates, re-operation rates 
and early mortality rates were recorded for both groups. The 
Down syndrome group appeared to benefit more from cardiac 
surgery than the non-Down syndrome group. 
Conclusion. Denying cardiac surgery to children with Down 
syndrome does not improve the efficiency of resource 
allocation. It is therefore not reasonable to suggest that 
the .problem of scarce resources can be ameliorated by 
discriminating against children with Down syndrome. 
S Afr Med J 2006; 96: 924-930. 
child makes in society, perceived as less significant, does 
not warrant the child's utilisation of scarce resources. This is 
best illustrated by the well-publicised case of Baby Ronnie, 
who was denied surgical repair of tetralogy of Fallot by the 
Gauteng Department of Health in 2001 on the basis of having 
Down syndrome.5 Down syndrome children are relatively 
easy to identify clinically, and diagnosis can be confirmed by 
chromosomal analysis, which may predispose these children 
to being the target of discrimination in the allocation of scarce 
resources.6 
The ethical position regarding treatment strategies for 
Down syndrome children with congenital heart disease 
(CHD) is debated internationally,7 and there is evidence that 
more institutions worldwide are offering the same treatment 
methods for CHD to children with and without Down 
syndrome.8 For details of the dialectic about whether or not 
to offer surgical correction of CHD to children with Down 
syndrome in South Africa please refer to Lawrenson et al.6 
The lack of a national policy in South Africa to govern the 
treatment of Down syndrome children who have CHD has led 
to diverse treatment strategies in different provinces. As yet, 
there appears to be insufficient evidence relevant to the South 
African context on which to base policy decisions. 
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Currently, in South Africa, Red Cross War Memorial 
Children's Hospital (RXH) in Cape Town offers surgical 
treatment to Down syndrome children with CHD. At this 
public hospital, it is believed that there is no significant 
reason to discriminate against these children. However, some 
specialist public institutions in South Africa that are in a 
position to provide surgical care for Down syndrome children 
with CHD do not follow this policy. 
This study compares the burden that Down syndrome 
children place on health resources with that placed by non-
Down syndrome children in respect of palliation or correction 
of CHD at RXH. It is not a health economic analysis and does 
not attempt to address the overall burden placed on health care 
resources by children with Down syndrome. This is beyond the 
scope of our review. To do so would require life-long economic 
analyses of cohorts of children with Down syndrome who have 
and have not undergone cardiac surgery. At RXH we do not 
have access to the latter cohort, since all our Down syndrome 
children are offered surgery and are only excluded on the 
grounds of cardiological criteria rendering them unsuitable for 
palliative or corrective surgery. Rather, our review quantifies 
the burden (in terms of the parameters outlined below) on 
cohorts of children with and without Down syndrome who 
have undergone cardiac surgery at RXH over a 5-year period. 
Inferences will be drawn from this experience. 
Methods 
Selection of subjects 
A list of children who had undergone cardiac surgery at RXH 
from January 1998 to June 2003 was generated and sorted 
according to the date of surgery. The RXH Intensive Care Unit 
(ICU) and the University of Cape Town (UCT) Cytogenetics 
Laboratory databases were used to identify the sample group 
of 50 Down syndrome children (whose files were available 
for review). The control group of 50 children was created 
from the same cardiac surgery list by selecting the non-Down 
syndrome child on the list following immediately after each 
Down syndrome child in the sample group. Any child that 
was clinically identifiable as having a syndromic disease (e.g. 
Williams syndrome, 22q deletion syndrome) was excluded 
from the study. This exclusion was necessary in order to draw 
a comparison between Down syndrome children and children 
that were not clinically syndromic. 
This method of selection was chosen to minimise the impact 
that variable medical staff and facilities over the 5-year period 
would have had on the management of the patients. There 
was no intentional matching of Down syndrome children 
with non-Down syndrome children according to the type of 
cardiac defect, as an impractically larger number of subjects 
would have had to be reviewed in order to make such a 
comparison owing to the variance of cardiac lesions between 
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the two groups. Attempts to extend the study to include 
children operated on in 1996 and 1997 failed owing to the 
poor availability of patient information. There was also no 
intentional matching of samples according to the type of 
cardiac surgical procedure for the same reason. However, it is 
important to note that at other institutions Down syndrome 
children are denied consideration for cardiac surgery 
irrespective of the type of defect present or procedure required. 
Patients' medical files were retrospectively reviewed. Case 
notes were used to determine patient details such as age, sex, 
diagnoses (cardiac and non-cardiac), dates of admission and 
discharge (to and from hospital and ICU), surgical details and 
mortality. Late mortality rates were not determined because 
of resource constraints. Data regarding admissions to other 
hospitals were not included in this study. No other state 
hospital in the Western or Eastern Cape offers a comprehensive 
cardiology and cardiac surgery service to children. 
Measurements 
In order to evaluate the burden to the public health care 
system, the groups were compared in terms of the number of 
days spent in a general hospital ward and in the ICU. 
Benefit derived from cardiac surgery was evaluated by 
determining the number of days spent in RXH (only) before 
the first cardiac surgical procedure, between procedures 
(for children who received more than one cardiac surgical 
procedure) and after final palliation. Since some children did 
not undergo their final palliation during the study period, any 
children requiring anticipated further cardiac surgery were 
enumerated. Children who had been recorded as deceased 
were excluded from this enumeration. 
The postoperative course was evaluated by determining 
the frequency of re-operations, complications of surgery 
and rate of early mortality for both groups. Early mortality 
is defined as death after cardiac surgery prior to discharge. 
Resource constraints prevented the determination of late 
mortality rates and prolonged follow-up at hospitals other 
than RXH. 
Admissions for investigative purposes only (e.g. cardiac 
catheterisation) were included in the number of admissions 
before and after surgery. This allowed a comparison of 
hospital resources utilised by both groups even though these 
admissions represent the health professional's request for the 
patient's admission and not necessarily the patient's need for 
admission as a result of illness. 
Data management and analysis 
Data were recorded in an MS Access database designed 
specifically for this study. MS Excel and Stata v.8 were used 
to process, summarise and present data. The chi-squared test 
was used to test for statistical associations between categorical 




of the chi-squared test in the event of a cell size less than 5. 
Numerical variables were compared using the two-sample 
Wilcoxon rank-sum test and the Wilcoxon signed-rank test 
where appropriate and are given as mean, median, standard 
deviation (SD) and range. 
Results 
Sex 
The Down syndrome group consisted of 31 females (62%) and 
19 males (38%). The non-Down syndrome group consisted of 
28 females (56%) and 22 males (44%), p = 0.542. 
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Fig. 1. Distribution of cardiac diagnoses in cohorts of Down syndrome 
and non-Down syndrome children who have undergone cardiac surgery 
80 
at Red Cross War Memorial Children's Hospital between January 1998 
and June 2003. AVSD- atrioventricular septal defect; ASD- atrial septal 
defect; VSD- ventricular septal defect; PDA- patent ductus arteriosus; 
RVOT obstruction- right ventricular outflow tract obstruction; MAPCA 
-multiple aorta-pulmonary connecting arteries; RHD- rheumatic heart 
disease; TGA- transposition of the great arteries; DORV- double outlet 
right ventricle; PAPVD- partial anomalous pulmonary venous drain-
age; TAPVD- total anomalous pulmonary venous drainage; RPA- right 
pulmonary artery; DILV- double inlet left ventricle. Error bars represent 
2 standard deviations. 
September 2006, Vol. 96, No. 9 SAMJ 
Cardiac diagnoses 
The distribution of cardiac defects in the Down syndrome 
group is markedly different to that in the non-Down 
syndrome group. Fig. 1 illustrates the observed frequency 
of all cardiac diagnoses, which are not necessarily isolated 
diagnoses. The Down syndrome group showed less 
variance than the non-Down syndrome group in terms of 
the type of cardiac defects present with 11 and 24 different 
cardiac diagnoses recorded respectively. Atrioventricular 
septal defects (AVSDs, p < 0.0005) and patent ductus 
arteriosus (PDA, p = 0.017) were observed to be 
significantly more common in the Down syndrome group 
than in the non-Down syndrome group. Ventricular septal 
defects (VSDs), atrial septal defects (ASDs) and tetralogy 
of Fallot were common and were similarly distributed 
in the two groups. Other notable differences in the 
diagnoses shown in Fig. 1 include transposition of the great 
arteries (TGA), rheumatic heart disease (RHD) and aortic 
coarctation, which were each observed with a frequency of 
8% in the non-Down syndrome group, but were absent in 
the Down syndrome group (Fisher's exact test p = 0.117, 1-
sided Fisher's exact test p = 0.059). 
Non-cardiac diagnoses 
A total of 182 non-cardiac diagnoses were recorded for the two 
groups. The Down syndrome group contributed 105 diagnoses 
(57.7%) while the non-Down syndrome group contributed 
77 diagnoses (42.3%) to this total. The two groups once again 
showed variance in the distribution of these diagnoses (Fig. 2). 
Notably, respiratory tract infections (RTls) were observed in 40 
Down syndrome children (80%) and 28 non-Down syndrome 
children (56%, p = 0.010). Gastroenteritis or diarrhoea was 
observed in 17 Down syndrome children (34%) and 9 non-
Down syndrome children (18%, p = 0.068). Other non-cardiac 
diagnoses recorded less frequently that are worth highlighting 
Fig. 2. Non-cardiac diagnoses in cohorts of Down syndrome and non-
Down syndrome children who underwent cardiac surgery at Red Cross 
War Memorial Children's Hospital between January 1998 and June 2003. 
RTI- respiratory tract infection; COR- gastro-oesophageal reflux; CCF 
-congestive cardiac failure; PTB- pulmonary tuberculosis. Error bars 
represent 2 standard deviations. 
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include gastro-oesophageal reflux (GOR) recorded in 7 
Down syndrome children (14%) but absent in the non-Down 
syndrome group (p = 0.012), and pulmonary tuberculosis 
(PTB) recorded in 5 non-Down syndrome children (10%) but 
absent in the Down syndrome group (p = 0.056). No significant 
difference was recorded between the two groups in respect of 
any of the remaining non-cardiac diagnoses. 
Burden to the health system 
The Down syndrome group tended to spend more time in 
general wards (2 004 days) and in the ICU (437 days) than 
the non-Down syndrome group (1 420 days and 344 days, 
respectively). However, there is no significant difference 
between the two groups in this regard (Table I). The Down 
syndrome group displayed a greater variance in the time spent 
in hospital per patient. This is evident in the greater range 
of days spent in hospital, the general wards and ICU by the 
Down syndrome group in comparison with the non-Down 
syndrome group (Table I). The total time spent in hospital for 
cardiac surgery, the general ward preparation and recovery 
time as well as the ICU recovery time for the two groups was 
remarkably similar (Table II). 
Benefit of surgery 
The age at first surgery for the Down syndrome group 
(median: 9.5 months; range: 102.8 months) was significantly 
less (p < 0.05) than the non-Down syndrome group (median: 
15.6 months; range 178.3 months). Nevertheless, the Down 
syndrome group spent significantly more time in hospital than 
the non-Down syndrome group before surgical intervention. 
The two groups spent a similar amount of time in the hospital 
between cardiac surgical procedures, as well as after cardiac 
surgery (Table III). The Down syndrome group showed a 
significant reduction in the mean number of days spent in 
hospital per patient after having had cardiac surgery, p = 0.014 
(Fig. 3). In contrast, the non-Down syndrome group did not 
show a significant reduction, p = 0.0843. 
In the Down syndrome group, 7 children (14%) were 
expected to return for planned further cardiac surgery, while in 
the non-Down syndrome group, only 4 children (8%, p = 0.338) 
were expected to do so (Fig. 4). 
Postoperative course 
The Down syndrome group displayed a lower postoperative 
complication rate (p = 0.205), re-operation rate (Fisher's exact 
test p = 1, 1-sided Fisher's exact test p = 0.5) and early mortality 
rate (p = 0.538) than the non-Down syndrome children (Fig. 4); 
however, these differences are not significant. The distribution 
of postoperative complications was dissimilar for the two 
groups; the most common postoperative complications in both 
groups were RTis, pericardia! effusions and sepsis (Fig. 5). The 
differences in the frequencies of these complications were not 
significant. 
Discussion 
There is substantial evidence to show that the survival profile 
of Down syndrome children worldwide has been improving 
remarkably over the past 5 decades,8-10 although the average 
Table I. Comparison of total days spent in hospital and ICU for any reason 
Percentage of days in ICU I 
Days in hospital Days in general ward Days iniCU days in hospital 
DS Non-DS p DS Non-DS p DS Non-DS p DS Non-DS p 
Mean 48.82 35.28 40.08 28.4 8.74 6.88 21.78 22.1 
Median 36.5 30.5 0.085 31 21. 5 0.110 5 4 0.141 15.65 17.29 0.858 
SD 39.19 26.48 33.77 23.27 10.75 7.9 19.04 18.34 
Range 165 120 146 110 60 20 82.12 78.04 
DS.:::::. Down syndrome; ICU ::o: intensive care unit; SD = standard deviation. 
Table II. Number of days spent in hospital in preparation of and recovery from cardiac surgery 
Total time in hospital for GW preparation for cardiac ICU recovery from cardiac GW recovery from cardiac 
cardiac surgery (days) surgery (days) surgery (days) surgery (days) 
DS Non-DS p DS Non-DS p DS Non-DS t!. DS Non-DS t!. 
Mean 29.72 23.72 16.86 11.22 6.54 6.2 12.86 12.5 
Median 15.5 17.5 0.707 6 5 0.408 4.5 4 0.311 8 8 0.961 
SD 41.43 29.82 26.83 14.62 7.15 7 18.94 19.24 
Range 255 200 132 67 41 32 123 134 
DS = Down syndrome; GW = general ward; ICU =intensive care unit; SD = standard deviation. 
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Fig. 4. Postoperative course in cohorts of Down syndrome and non-Down 
syndrome children who underwent cardiac surgery at Red Cross War 
Memorial Children's Hospital between January 1998 and June 2003. Error 
bars represent 2 standard deviations. 
life expectancy for someone with Down syndrome is still 
approximately 20 years less than that of a person without 
Down syndrome.9 This improvement has largely been 
attributed to advancements in cardiac surgery and to the 
higher proportion of institutions that are offering the same 
management strategy for CHD to Down syndrome children 
Fig. 5. Post-operative complications in cohorts of Down syndrome and 
non-Down syndrome children who underwent cardiac surgery at Red 
Cross War Memorial Children's Hospital between january 1998 and June 
2003. RTI- respiratory tract infection; DIC- disseminated intravascular 
coagulopathy; CPR- cardiopulmonary resuscitation. Error bars represent 
2 standard deviations. 
as they offer to non-Down syndrome children.8•9 More 
importantly, the survival profile of Down syndrome children 
with surgically treated CHD has been shown to be similar 
for Down syndrome children without CHD.4•11 This is an 
indication that surgical intervention is being utilised effectively 
abroad. 
The disparity in the treatment strategies offered by different 
public health institutions in South Africa may be the result 
of misconceptions regarding the benefit of surgical treatment 
of CHD of children with Down syndrome. This is evident in 
the statements issued by the Gauteng Provincial Government 
in response to the case of Baby Ronnie: that Down syndrome 
children represent about 30% of children with cardiac problems 
and that Down syndrome children have more complex 
heart lesions and are usually more prone to life-threatening 
complications as a result of surgery. 
12 
Firstly, the prevalence of Down syndrome in all patients 
requiring cardiac surgery has convincingly been reported as 
approximately 9%,3 not 30%. 
Secondly, the policy of offering surgical treatment to Down 
syndrome children for CHD at RXH is qualified ethically 
Table III. Benefit of surgery in terms of number of days spent in hospital 
Between cardiac surgical procedures 
Before cardiac surgery (days) (days) After cardiac surgery (days) 
OS Non-DS p DS Non-DS p OS Non-DS p 
Mean 10.8 5.78 3.24 1.04 2.9 1.2 
Median 2.5 0 0.002 0 0 0.846 0 0 0.172 
SD 16 15.93 8.6 10.41 5.87 3.06 
Range 65 86 44 21 28 15 
DS "' Down syndrome; SD ~ standard deviation. 
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by Lawrenson et a/. 6 and has been qualified in terms of cost 
efficiency by this study and previous studies. Ungerleider 
et a/. 13 used a cost tracking system to demonstrate that Down 
syndrome children had a less predictable cost picture in 
the repair of VSDs than children without Down syndrome, 
but the presence of Down syndrome did not influence the 
risk of higher costs in the repair of other CHDs. Our study 
demonstrates that Down syndrome children undergoing 
surgical treatment of CHD do not spend significantly more 
time in hospital or in the ICU than their non-Down syndrome 
counterparts, and thus, the two groups appear to place a 
similar burden on the health care system (Table I). 
Weintraub et a/.14 and Rizolli et a/. 15 demonstrated that Down 
syndrome children required fewer re-operations and compared 
favourably on clinical and echocardiographic investigation 
than children without Down syndrome in the surgical 
management of AVSD. In this study, the two groups showed 
a similar postoperative course in terms of postoperative 
complications, re-operations and early mortality (Fig. 4). It is 
important to note that the early mortality rates of 10% in the 
Down syndrome group and 14% in the non-Down syndrome 
group recorded in this study were higher than the early 
mortality rates recorded over the past 10 years for children 
undergoing cardiac surgery at RXH - the lowest annual early 
mortality rate was 3.6% and the highest was 9% (personal 
observation). 
Evaluating the long-term survival of the two groups was 
outside the scope of this study. The expected 1-year survival 
rate of children with Down syndrome has been reported as 
approximately 90% with a 10-year survival rate of about 80%.8'9 
Various studies have reported a life expectancy for children 
with Down syndrome in the 50s9 with 25 - 45% surviving to 
the age of 60 years.15,16 It has been demonstrated that these 
survival rates are significantly less than those of the general 
population where a 60-year survival rate of approximately 85% 
has been demonstrated.17 Recent long-term survival rates for 
Down syndrome people in South Africa are not available. 
There are various factors that appear to be more important 
predictors of the outcome of cardiac surgery than the presence 
of Down syndrome. These include the preoperative medical 
condition of the child/7'18 the anatomical complexity of the 
cardiac lesion}7'19 and the timing of surgical intervention.15'18'20 
The management of the preoperative medical condition 
is necessary for any child undergoing cardiac surgery since 
the high frequency of associated non-cardiac diagnoses is 
not unique to Down syndrome children/7 and is confirmed 
in this study (Fig. 2). It is generally accepted that AVSDs (a 
complex cardiac lesion) constitute 40 - 60% of cardiac lesions 
in Down syndrome children with CHD while AVSDs are 
uncommon in children without Down syndrome.2'21 However, 
the most complex forms of this lesion, together with other 
complex lesions such as TGA, are usually found in non-Down 
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syndrome children, and are less favourable to repair.2.15'19 This 
distribution of cardiac diagnoses is consistent with the findings 
in this study (Fig. 1). It is well established that early repair 
is recommended in any child with CHD.15•18 This appears to 
be especially important in Down syndrome children in order 
to prevent associated pulmonary diseases since they have a 
higher propensity for early pulmonary hypertension than non-
Down syndrome children.3 
In this study the Down syndrome group appeared to benefit 
more from the cardiac surgery than the non-Down syndrome 
group. This is evident in the finding that the Down syndrome 
group showed a significant reduction in the time spent in 
hospital after having received cardiac surgery whereas the non-
Down syndrome group did not show a significant reduction. 
This is further evidence to support the need for cardiac surgery 
in Down syndrome children with CHD and may indicate that 
not operating on these children may result in more hospital 
resources being consumed. 
The significance of the preponderance of females in both 
groups for this study is questionable, given the size of the 
study population. However, previous studies have reported 
similar findings. 9•11 
The difference in the distribution of cardiac diagnoses 
prevented a comparison between the two groups according 
to the type of defect present and type of surgical procedure 
required. However, as previously mentioned, the type of 
cardiac lesion is not one of the criteria for consideration for 
cardiac surgery. 
Conducting a study of this nature in collaboration with other 
health care facilities in South Africa that offer surgical repair of 
CHD would provide an understanding of the problem in the 
broader context of South Africa. 
Conclusion 
This study demonstrates that cardiac surgery in Down 
syndrome children does not place a significantly greater 
burden on the health care system than in non-Down syndrome 
children with CHD, and that, in this comparison, Down 
syndrome children appear to benefit more. The postoperative 
course for the two groups of children is similar. Denying 
cardiac surgery to children with Down syndrome may 
therefore not improve the efficiency of resource allocation, 
especially since the number of cardiac surgical procedures 
performed on Down syndrome children is a small proportion 
of the total surgical load. It therefore appears unreasonable 
to suggest that discriminating against children with Down mJ 
syndrome will ameliorate the problem of scarce resources. For 
these reasons we conclude that cardiac surgery is warranted 
in children with Down syndrome. This review, however, does 
not attempt to quantify the broader health economic issues of 
an interventional versus a conservative approach to CHD in 
children with Down syndrome. This review is the first South 
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African audit of an interventional management programme 
for CHD in Down syndrome children, and falsifies the widely 
held misconception that cardiac surgery in Down syndrome 
children is more complex and costly than on non-syndromic 
children. This argument can therefore no longer be used for the 
motivation or defence of non-intervention in the South African 
context. 
It is clear that the health care system is limited less by the 
technology and skills involved in treatment strategies and more 
by the resources available to fund such strategies as medical 
advancement continues with alacrity. As a result, doctors are 
frequently faced with moral choices in which medical needs, 
ethical issues and economic constraints are conflated to the 
degree that correct and incorrect practice and the pursuit of 
optimal health care become an abyss of uncertainty. 
The results of this study are evidence, relevant in the South 
African context, of the benefit to be derived by the surgical 
management of CHD in children with Down syndrome, a 
benefit readily realised in the formulation and implementation 
of more appropriate policy. 
'Happiness is not an ideal of reason but of imagination.' 
-Immanuel Kant (1724- 1804). Fundamental Principles of 
the Metaphysics of Ethics (1785) 
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